Expression alteration of microRNAs in Nucleus Accumbens is associated with chronic stress and antidepressant treatment in rats

Background Nucleus Accumbens (NAc) is a vital brain region for the process of reward and stress, whereas microRNA plays a crucial role in depression pathology. However, the abnormality of NAc miRNA expression during the stress-induced depression and antidepressant treatment, as well as its biological significance, are still unknown. Methods We performed the small RNA-sequencing in NAc of rats from three groups: control, chronic unpredictable mild stress (CUMS), and CUMS with an antidepressant, Escitalopram. We applied an integrative pipeline for analyzing the miRNA expression alternation in different model groups, including differential expression analysis, co-expression analysis, as well as a subsequent pathway/network analysis to discover both miRNA alteration pattern and its biological significance. Result A total of 423 miRNAs were included in analysis.18/8 differential expressing (DE) miRNA (adjusted p < 0.05, |log2FC| > 1) were observed in controls Vs. depression/depression Vs. treatment, 2 of which are overlapping. 78% (14/18) of these miRNAs showed opposite trends of alteration in stress and treatment. Two micro RNA, miR-10b-5p and miR-214-3p, appeared to be hubs in the regulation networks and also among the top findings in both differential analyses. Using co-expression analysis, we found a functional module that strongly correlated with stress (R = 0.96, P = 0.003), and another functional module with a moderate correlation with anhedonia (R = 0.89, P = 0.02). We also found that predicted targets of these miRNAs were significantly enriched in the Ras signaling pathway, which is associated with both depression, anhedonia, and antidepressant treatment. Conclusion Escitalopram treatment can significantly reverse NAc miRNA abnormality induced by chronic stress. However, the novel miRNA alteration that is absent in stress pathology also emerges, which means that antidepressant treatment is unlikely to bring miRNA expression back to the same level as the controls. Also, the Ras-signaling pathway may be involved in explaining the depression disease etiology, the clinical symptom, and treatment response of stress-induced depression.

[1]  MicroRNA Expression Profile and Functional Analysis Reveal that miR-206 is a Critical Novel Gene for the Expression of BDNF Induced by Ketamine , 2014, NeuroMolecular Medicine.

[2]  Zachary S. Lorsch,et al.  Sex Differences in Nucleus Accumbens Transcriptome Profiles Associated with Susceptibility versus Resilience to Subchronic Variable Stress , 2015, The Journal of Neuroscience.

[3]  C. D. De Zeeuw,et al.  Ablation of TFR1 in Purkinje Cells Inhibits mGlu1 Trafficking and Impairs Motor Coordination, But Not Autistic-Like Behaviors , 2017, The Journal of Neuroscience.

[4]  M. Papp,et al.  Reciprocal MicroRNA Expression in Mesocortical Circuit and Its Interplay with Serotonin Transporter Define Resilient Rats in the Chronic Mild Stress , 2016, Molecular Neurobiology.

[5]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[6]  Li-Tao Yi,et al.  7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK/Akt signaling pathways in mice exposed to chronic unpredictable mild stress , 2014, Psychopharmacology.

[7]  M. Shayesteh,et al.  Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial , 2016, European Journal of Clinical Pharmacology.

[8]  Kerang Zhang,et al.  Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls. , 2016, Journal of affective disorders.

[9]  M. Barbosa,et al.  Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications , 2015, Journal of Medical Genetics.

[10]  D. Bartel,et al.  Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.

[11]  C. Lewis,et al.  MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes , 2017, Nature Communications.

[12]  Fang Wang,et al.  miR-214-3p Targets &bgr;-Catenin to Regulate Depressive-like Behaviors Induced by Chronic Social Defeat Stress in Mice , 2019, Cerebral cortex.

[13]  I. Armando,et al.  Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists , 2005, Regulatory Peptides.

[14]  T. Abel,et al.  MicroRNAs as biomarkers of resilience or vulnerability to stress , 2015, Neuroscience.

[15]  R. Cui,et al.  The Effects of Psychological Stress on Depression , 2015, Current neuropharmacology.

[16]  E. Nestler,et al.  The brain reward circuitry in mood disorders , 2013, Nature Reviews Neuroscience.

[17]  A. Amare,et al.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry , 2017, EPMA Journal.

[18]  Y. Akao,et al.  MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation , 2012, Neurochemistry International.

[19]  Yogesh Kumar Dwivedi,et al.  The Involvement of MicroRNAs in Major Depression, Suicidal Behavior, and Related Disorders: A Focus on miR-185 and miR-491-3p , 2013, Cellular and Molecular Neurobiology.

[20]  Yogesh K. Dwivedi,et al.  MicroRNA Expression Is Down-Regulated and Reorganized in Prefrontal Cortex of Depressed Suicide Subjects , 2012, PloS one.

[21]  Yogesh K. Dwivedi,et al.  Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder , 2016, Neuropsychopharmacology.

[22]  J. Clayton-Smith,et al.  Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder , 2010, Clinical dysmorphology.

[23]  L. Giner,et al.  A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime , 2018, Current Psychiatry Reports.

[24]  G. Turecki,et al.  Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants , 2017, CNS Drugs.

[25]  Xing Liu,et al.  MiR-218 targets MeCP2 and inhibits heroin seeking behavior , 2017, Scientific Reports.

[26]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[27]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[28]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[29]  Guanghua Xiao,et al.  Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli , 2007, Neuron.

[30]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[31]  Charles R. Yang,et al.  Current perspectives of the roles of the central norepinephrine system in anxiety and depression , 2010, Depression and anxiety.

[32]  Zhiheng Xu,et al.  Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity , 2016, Scientific Reports.

[33]  Yogesh K. Dwivedi.  microRNA-124: a putative therapeutic target and biomarker for major depression , 2017, Expert opinion on therapeutic targets.

[34]  Li Liu,et al.  Abnormal Expression of MicroRNAs Induced by Chronic Unpredictable Mild Stress in Rat Hippocampal Tissues , 2017, Molecular Neurobiology.

[35]  K. Irie,et al.  MicroRNA-214 Promotes Dendritic Development by Targeting the Schizophrenia-associated Gene Quaking (Qki)* , 2016, The Journal of Biological Chemistry.

[36]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[37]  W. Liu,et al.  MicroRNA-214 modulates neural progenitor cell differentiation by targeting Quaking during cerebral cortex development , 2017, Scientific Reports.

[38]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[39]  J. Smyth,et al.  Timing matters: the interval between acute stressors within chronic mild stress modifies behavioral and physiologic stress responses in male rats , 2018, Stress.

[40]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[41]  Xuegong Zhang,et al.  DEGseq: an R package for identifying differentially expressed genes from RNA-seq data , 2010, Bioinform..

[42]  Zachary S. Lorsch,et al.  Integrative Analysis of Sex-Specific microRNA Networks Following Stress in Mouse Nucleus Accumbens , 2016, Front. Mol. Neurosci..

[43]  A. Hofman,et al.  Angiotensinogen M235T polymorphism and symptoms of depression in a population-based study and a family-based study , 2008, Psychiatric genetics.

[44]  Yamei Liu,et al.  Effects of duloxetine on microRNA expression profile in frontal lobe and hippocampus in a mouse model of depression. , 2015, International journal of clinical and experimental pathology.

[45]  A. Carvalho,et al.  The miRNome of bipolar disorder. , 2017, Journal of affective disorders.

[46]  Miguel Arturo Barreto-Sanz,et al.  miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease , 2018, Oncotarget.

[47]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[48]  Chia-Chen Liu,et al.  Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants. , 2015, Journal of affective disorders.

[49]  Stephen J. Guter,et al.  Co‐occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion , 2013, American journal of medical genetics. Part A.

[50]  Yogesh K. Dwivedi,et al.  Dissecting bipolar disorder complexity through epigenomic approach , 2016, Molecular Psychiatry.

[51]  R. Beyer,et al.  Dose-Dependent Effects of Morphine Exposure on mRNA and microRNA (miR) Expression in Hippocampus of Stressed Neonatal Mice , 2015, PloS one.

[52]  N. Wu,et al.  Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases , 2013, Cellular and Molecular Neurobiology.

[53]  Jianxin Shi,et al.  Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. , 2011, The American journal of psychiatry.

[54]  Chunxiang Zhang,et al.  MicroRNA expression profile and functional analysis reveal that miR-382 is a critical novel gene of alcohol addiction , 2013, EMBO molecular medicine.

[55]  K. Ritchie,et al.  Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression , 2013, Translational Psychiatry.

[56]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[57]  Suxia Han,et al.  fied, along with their associated protein‐protein interaction networks and Kyoto Encyclopedia of Genes and Genomes , 2019 .

[58]  Yaping Wang,et al.  G-CSF improves CUMS-induced depressive behaviors through downregulating Ras/ERK/MAPK signaling pathway. , 2016, Biochemical and biophysical research communications.

[59]  R. Geffers,et al.  Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations , 2017, Journal of Molecular Neuroscience.

[60]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[61]  José N. Nobrega,et al.  Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects , 2014, Neuroscience & Biobehavioral Reviews.

[62]  Zachary S. Lorsch,et al.  Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility , 2016, Neuron.

[63]  E. Nestler,et al.  Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles , 2017, Biological Psychiatry.

[64]  Nan Miao,et al.  Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice , 2018, International journal of molecular sciences.